Helen Collins
2019
In 2019, Helen Collins earned a total compensation of $1.6M as Executive Vice President and Chief Medical Officer at Five Prime Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $503,664 |
| Salary | $456,253 |
| Stock Awards | $461,660 |
| Other | $6,000 |
| Total | $1,602,578 |
Collins received $503.7K in option awards, accounting for 31% of the total pay in 2019.
Collins also received $175K in non-equity incentive plan, $456.3K in salary, $461.7K in stock awards and $6K in other compensation.
Rankings
In 2019, Helen Collins' compensation ranked 7,011th out of 13,971 executives tracked by ExecPay. In other words, Collins earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,011 out of 13,971 | 50th |
Division Manufacturing | 2,684 out of 5,692 | 53rd |
Major group Chemicals And Allied Products | 987 out of 2,189 | 55th |
Industry group Drugs | 836 out of 1,875 | 55th |
Industry Pharmaceutical Preparations | 614 out of 1,387 | 56th |
Source: SEC filing on April 3, 2020.
Collins' colleagues
We found three more compensation records of executives who worked with Helen Collins at Five Prime Therapeutics in 2019.